References
- Anal AK. (2007). Stimuli-induced Pulsatile or Triggered Release Delivery Systems for Bioactive Compounds. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 1, 83–90.
- Cha R, Rybak MJ. (2004). Pulsatile delivery of amoxicillin against Streptococcus pneumoniae. J Antimicrob Chemother, 54, 1067–1071.
- Crison JR, Siersma PR, Lipka E, Taylor MD, Amidon GL. (1995). Programmable oral release technology PORT system: a novel dosage form for time and site specific oral drug delivery. Proc Int Symp Control Release Bioactive Mater, 22, 278–279.
- Flanner H, Treacy D, Beth B. (2008). Modified release amoxicillin products. US20080132478.
- Held K, Marolf T, Erni W. (1990). Principle and development of a tablet formulation with pulsatile drug delivery after a controlled and pH dependent latency period. Acta Pharm Technol, 36, 38s.
- Kim B, Peppas NA. (2003). In vitro release behavior and stability of insulin in complexation hydrogels as oral drug delivery carriers. Int J Pharm, 266, 29–37.
- Klein S, Stein J, Dressman J. (2005). Site-specific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in-vitro release model. J Pharm Pharmacol, 57, 709–719.
- Lee WW, Wilson CG, Mukherjee G. (2003). Time dependent systems for colonic delivery. In: Rathbone MJ, Hadgraft J, Roberts MS, ed. Modified release drug delivery technology. New York: Marcel Dekker, 247–248.
- Lévi F. (2006). Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes Control, 17, 611–621.
- Lerner I, Flashner M, Penhasi A. (2003). Immediate release gastrointestinal drug delivery system. US6531152B1.
- Magruder P, Barclay B, Wong PSL, Theeuwes F. (1988). Composition comprising salbutamol. US4751071.
- McNeill ME, Rashid A, Stevens HNE. (1993). Drug dispensing device. GB2230442.
- Ross AC, MacRae RJ, Walther M, Stevens HN. (2000). Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J Pharm Pharmacol, 52, 903–909.
- Rudnic E, Isbister J, Donald J. (2006). Multiple delayed released antibiotic product, use and formulation thereof. US7025989.
- Saigal N, Baboota S, Ahuja A, Ali J. (2009a). Multiple-pulse drug delivery systems: setting a new paradigm for infectious disease therapy. Expert Opin Drug Deliv, 6, 441–452.
- Saigal N, Baboota S, Ahuja A, Ali J. (2009b). Site specific chronotherapeutic drug delivery systems: a patent review. Recent Pat Drug Deliv Formul, 3, 64–70.
- Shaw E, Tofler GH. (2009). Circadian rhythm and cardiovascular disease. Curr Atheroscler Rep, 11, 289–295.
- Smith DH, Neutel JM, Weber MA. (2001). A new chronotherapeutic oral drug absorption system for verapamil optimizes blood pressure control in the morning. Am J Hypertens, 14, 14–19.
- Stevens HNE, Ross AC, Johnson JR. (2001). The hydrophilic-sandwich (HS) capsule: a convenient time delayed oral probe device. J Pharm Pharmacol, 52, s41.
- Ueda Y, Hata T, Yamaguchi H. (1989). Time-controlled explosion systems. US4871549.
- Wong PSL, Theeuwes P, Larsen SD. (1994). Osmotic device for delayed delivery of agent. US5312388.